IRONWOOD PHARMACEUTICALS, INC.: operating_income
| Value | {"amount": -945430000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | IRONWOOD PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:17:27.359485+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0f3bd28c-8cfd-47fb-a748-cb9e573ee51e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-24-001275Retrieved: 2026-08-19T14:17:27.359485+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001446847/operating-income/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0f3bd28c-8cfd-47fb-a748-cb9e573ee51e
History
- no predecessors — first report